RA
AGN

Ramius Advisors’s Allergan plc AGN Stock Holding History

Ramius Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-304,911
Closed -$54M – 73
2020
Q1 		$54M Buy
304,911
+640
+0.2% +$121K 13.67% 1
2019
Q4 		$58.2M Sell
304,271
-118,661
-28% -$21.4M 25.02% 1
2019
Q3 		$71.2M Buy
+422,932
New +$68.9M 16.71% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ramius Advisors's AGN Position: Q2 2020 in Review

Ramius Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 304,911 shares — an estimated $54M sold.

Ramius Advisors first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $71.2M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ramius Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ramius Advisors sold 304,911 Allergan plc shares in Q2 2020, an estimated $54M.
  • Ramius Advisors first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Ramius Advisors's Allergan plc position peaked at $71.2M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ramius Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.